The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Automated conversational artificial intelligence (AI) for outpatient malignant bowel obstruction (MBO) symptom monitoring.
 
Ainhoa Madariaga
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Pharma&
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; PharmaMar
Research Funding - Kyowa Kirin International
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD
 
Isabel Tuñon
No Relationships to Disclose
 
Sara Sánchez-Castro
No Relationships to Disclose
 
Marta Ruiz
No Relationships to Disclose
 
Ainhoa Herrero
No Relationships to Disclose
 
Carla Nuñez
No Relationships to Disclose
 
María Maiz
No Relationships to Disclose
 
Reyes Oliver
No Relationships to Disclose
 
Begoña Azcoitia
No Relationships to Disclose
 
Rodrigo Sanchez-Bayona
Honoraria - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Lilly; Novartis; Roche
Speakers' Bureau - AstraZeneca; Novartis
Expert Testimony - AstraZeneca; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
(OPTIONAL) Uncompensated Relationships - ESMO
 
Cristina González Deza
No Relationships to Disclose
 
Luis Manso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Tesaro
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Novartis; Roche/Genentech; Tesaro
 
María Pérez
No Relationships to Disclose
 
Pablo Tolosa Ortega
Consulting or Advisory Role - Adamed; AstraZeneca; Daiichi Sankyo; Menarini; MSD Oncology; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer
 
Manuel Alva Bianchi
No Relationships to Disclose
 
Laura Lema
Honoraria - Gilead Sciences; Novartis
 
Eva Ciruelos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; Novartis; Novartis; Pfizer; Reveal Genomics; Reveal Genomics; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Roche
Research Funding - Pfizer; Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Santiago Ponce Aix
Consulting or Advisory Role - Incyte (Inst); Pfizer (Inst)
Speakers' Bureau - AstraZeneca; Roche
 
Luis Paz-Ares
Leadership - ALTUM Sequencing; Stab Therapeutics
Stock and Other Ownership Interests - Altum Sequencing; Stab therapeutics
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; BMS; GlaxoSmithKline; Janssen; Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Pfizer; Pharmamar; Regeneron; Roche; Sanofi; Takeda
Speakers' Bureau - Amgen; AstraZeneca; BeiGene; BMS; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Astellas Pharma (I); Crinetics Pharmaceuticals (I); Esteve (I); HUTCHMED (I); Ipsen (I); ITM Isotope Technologies Munich (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Andrea Modrego
Travel, Accommodations, Expenses - Advanz Pharma; Fresenius; MSD Oncology; Novartis; Novartis; SERVIER